WebSAGE Complete Sage Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. WebApr 14, 2024 · What's Happening With SAGE Therapeutics Inc Stock Today? SAGE Therapeutics Inc (SAGE) stock is trading at $43.68 as of 1:57 PM on Friday, Apr 14, a loss …
Did you know?
WebDec 23, 2024 · Sage Therapeutics, Inc. Common Stock (SAGE) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. WebApr 12, 2024 · As a group, equities research analysts forecast that Sage Therapeutics, Inc. will post -8.11 earnings per share for the current year. Insider Buying and Selling at Sage Therapeutics. In other Sage Therapeutics news, Director Jeffrey M. Jonas sold 11,643 shares of the firm's stock in a transaction that occurred on Friday, February 10th.
WebSage Therapeutics is a biopharmaceutical company developing novel therapies for brain health disorders with Depression, ... News The latest from Sage press releases Sage … WebApr 10, 2024 · See the latest Sage Therapeutics Inc stock price (NASDAQ:SAGE), related news, valuation, dividends and more to help you make your investing decisions.
WebApr 11, 2024 · As of April 11, 2024, 4:00 PM CST, SAGE Therapeutics Inc’s stock price was $43.33. SAGE Therapeutics Inc is up 4.59% from its previous closing price of $41.43. During the last market session, SAGE Therapeutics Inc’s stock traded between $40.65 and $41.61. Currently, there are 59.50 million shares of SAGE Therapeutics Inc stock available for ... WebNov 8, 2024 · Sage Therapeutics, Inc. , which belongs to the Zacks Medical - Drugs industry, posted revenues of $1.74 million for the quarter ended September 2024, surpassing the …
WebJan 8, 2024 · Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, today announced that Chief Executive Officer, Barry Greene, will discuss the Company’s progress in developing a leading brain health pipeline at the 41st Annual J.P. Morgan Healthcare Conference in San …
WebCAMBRIDGE, Mass., March 16, 2024--Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, … scan holderWebJan 29, 2016 · Sage Therapeutics. @SageBiotech. ·. Progressive and often inherited, #EssentialTremor (ET) is the most common movement disorder, impacting millions worldwide. As we shine a light on ET during … ruby file globWebMar 17, 2024 · CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar. 17, 2024-- Sage Therapeutics, Inc. (Nasdaq: SAGE) today reported complete 12-month data from the 30 mg cohort and … ruby figureWebApr 12, 2024 · Sage Therapeutics Price Performance. Shares of NASDAQ:SAGE opened at $43.33 on Wednesday. The company has a market capitalization of $2.59 billion, a P/E ratio of -4.83 and a beta of 1.16. scan home folderWebFeb 16, 2024 · CAMBRIDGE, Mass. – February 16, 2024 – Sage Therapeutics, Inc. (Nasdaq: SAGE), and Biogen Inc. (Nasdaq: BIIB) today announced the CORAL Study in people with major depressive disorder (MDD) met the trial objectives, demonstrating a rapid and statistically significant reduction in depressive symptoms at Day 3 and over the 2-week … ruby file extnameWebSage Therapeutics to Present at the Stifel 2024 CNS Days. CAMBRIDGE, Mass., March 22, 2024--Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the … scan here to learn moreWebSAGE Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel medicines. It targets diseases and disorders … ruby file foreach